Founder of Reata Pharmaceuticals, Inc., Circuit Therapeutics, Inc. and Neucyte, Inc., Thomas C. Südhof is an entrepreneur who currently holds the position of Venture Partner at Catalio Capital Management LP, Scientific Advisory Board at Simcere Pharmaceutical Group Ltd., Scientific Advisory Board at Elysium Pharmaceuticals Ltd., Scientific Advisory Board at Alector, Inc. and Scientific Advisory Board at Jupiter Therapeutics, Inc.

He is also on the board of Sanofi and CytoDel LLC and Member of The Royal Society, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Deutsche Akademie der Naturforscher Leopoldina eV, Professor at Stanford University School of Medicine and Member of The Royal Norwegian Society For Development.

In his past career he held the position of Member-Neuroscience Review Board at Genentech, Inc., Assistant Professor at The University of Texas Southwestern Medical Center and Research Assistant at Max Planck Institute For Biophysical Chemistry.

Thomas C. Südhof received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen.